Prognostic Role of E2F1 and Members of the CDKN2A Network in Gastrointestinal Stromal Tumors

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Cancer Research

• Publication date

  2005-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-05-0329PMID 16166437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.

  2005cited by this paper
• Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors

  2005cited by this paper
• Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal Tumors

  2004cited by this paper
• C-kit gene mutation in human gastrointestinal stromal tumors.

  2004cited by this paper
• Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)

  2004cited by this paper
• Role of p16/INK4a in gastrointestinal stromal tumor progression.

  2004cited by this paper
• Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization.

  2004cited by this paper
• Gene Expression in Gastrointestinal Stromal Tumors Is Distinguished by KIT Genotype and Anatomic Site

  2004cited by this paper
• A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential

  2004cited by this paper
• Transcriptional regulation of AKT activation by E2F.

  2004cited by this paper
• Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors

  2004cited by this paper
• Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles

  2004cited by this paper
• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Deletion of Trp‐557 and Lys‐558 in the juxtamembrane domain of the c‐kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors

  2003cited by this paper
• Specificity in the activation and control of transcription factor E2F-dependent apoptosis

  2003cited by this paper
• PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

  2003cited by this paper
• Gastrointestinal Stromal Tumors with Internal Tandem Duplications in 3′ End of KIT Juxtamembrane Domain Occur Predominantly in Stomach and Generally Seem to Have a Favorable Course

  2003cited by this paper
• High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors.

  2003cited by this paper
• Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.

  2002cited by this paper
• p14ARF regulates E2F activity

  2002cited by this paper
• Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.

  2002cited by this paper
• Diagnosis of gastrointestinal stromal tumors: A consensus approach.

  2002cited by this paper
• Transcription factor E2F‐1 acts as a growth‐promoting factor and is associated with adverse prognosis in non‐small cell lung carcinomas

  2002cited by this paper
• E2F1 selects tumour cells for both life and death

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• p19ARF targets certain E2F species for degradation

  2001cited by this paper
• KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

  2001cited by this paper
• Human ARF binds E2F1 and inhibits its transcriptional activity

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis

  2001cited by this paper
• E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

  2001cited by this paper
• The E2F1–3 transcription factors are essential for cellular proliferation

  2001cited by this paper
• The INK4a/ARF network in tumour suppression

  2001cited by this paper
• Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14ARF Tumor Suppressor

  2000cited by this paper
• KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.

  2000cited by this paper
• Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

  2000cited by this paper
• Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

  1998cited by this paper
• The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

  1996cited by this paper
• Gentleman R: R: A language for data analysis and graphics

  1996cited by this paper
• Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Differentiation and risk assessment of gastrointestinal stromal tumors.

  1995cited by this paper
• A novel p16INK4A transcript.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.

  1995cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Expression of transcription factor E2F1 induces quiescent cells to enter S phase

  1993cited by this paper
• Retinoblastoma protein switches the E2F site from positive to negative element

  1992cited by this paper
• Algorithms for Clustering Data

  1988cited by this paper
• Inhibition of cyclin D-CDK 4 / CDK 6 activity is associated with an E 2 F-mediated induction of cyclin kinase inhibitor activity ( human papillomaviruses / cervical cancer / E 7 oncoprotein / retinoblastoma protein )

  year unknowncited by this paper

• Clinical Utility of Liquid-based Comprehensive Genomic Profiling (CGP) in Gastrointestinal Stromal Tumors (GIST).

  2025cites this paper
• The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer

  2024cites this paper
• Novel structural variants that impact cell cycle genes are elucidated in metastatic gastrointestinal stromal tumors.

  2024cites this paper
• Genotypical analysis of gastrointestinal stromal tumors using next-generation sequencing

  2024cites this paper
• Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential

  2023cites this paper
• Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST

  2022cites this paper
• Construction and validation of a prognostic model for gastrointestinal stromal tumors based on copy number alterations and clinicopathological characteristics

  2022cites this paper
• ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer

  2021cites this paper
• E2F Transcription Factors in Cancer, More than the Cell Cycle

  2021cites this paper
• PRMT5 silencing selectively affects MTAP‐deleted mesothelioma: In vitro evidence of a novel promising approach

  2020cites this paper
• Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors

  2019cites this paper
• Mutational testing in gastrointestinal stromal tumor.

  2019cites this paper
• Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS)

  2019cites this paper
• Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype

  2019cites this paper
• Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment

  2018cites this paper
• Expression of p 16 predicts poor outcome for patients with gastrointestinal stromal tumors

  2017cites this paper
• Protein coding gene CRNKL1 as a potential prognostic biomarker in esophageal adenocarcinoma

  2017cites this paper
• Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies

  2017cites this paper
• Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor

  2017cites this paper
• Gastrointestinal Stromal Tumors (GISTs) of the Liver

  2017cites this paper
• Prognostic value of E2F1 in rectal cancer.

  2017cites this paper
• Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib.

  2017cites this paper
• Molecular and functional characterization of a new 3′ end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib

  2017cites this paper
• mutation status in gastrointestinal stromal tumors

  2016cites this paper
• Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.

  2016cites this paper
• Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor

  2015cites this paper
• Молекулярно-генетические особенности и маркеры гастроинтестинальных стромальных опухолей

  2015cites this paper
• Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors

  2015cites this paper
• Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour

  2014cites this paper
• Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).

  2014cites this paper
• High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors.

  2014cites this paper
• Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?

  2014cites this paper
• Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.

  2014cites this paper
• Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis

  2014cites this paper
• Predictive chromosomal clusters of synchronous and metachronous brain metastases in clear cell renal cell carcinoma.

  2014cites this paper
• Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis

  2014cites this paper
• Proteomic approach toward personalized sarcoma treatment: Lessons from prognostic biomarker discovery in gastrointestinal stromal tumor

  2013cites this paper
• Molecular Biology and Pathology of Gastrointestinal Stromal Tumors

  2013cites this paper
• Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations: Update on Genotype-Phenotype Correlation and Validation of a High-Resolution Melting Assay for Mutational Testing

  2013cites this paper
• Biomarkers and novel therapeutic targets in gastrointestinal stromal tumors (GISTs).

  2013cites this paper
• Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST).

  2012cites this paper
• GISTs: From the History to the Tailored Therapy

  2012cites this paper
• Genomic Grade Index predicts postoperative clinical outcome of GIST

  2012cites this paper
• Duodenal GIST: a single center experience

  2012cites this paper
• Thérapie prolongée au mesylate d'imatinib avant la chirurgie pour les tumeurs stromales gastrointestinales avancées : résultats d'une étude prospective de phase II

  2012cites this paper
• Matrix Metalloproteinase genes are transcriptionally regulated by E2F transcription factors: a link between cell cycle control and metastatic progression

  2012cites this paper
• Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST) Escore de expressão de Ki-67 correlaciona-se com taxa de sobrevida em tumores estromais gastrointestinais (GIST)

  2012cites this paper
• Expression of DOG1, PDGFRA, and p16 in Gastrointestinal Stromal Tumors

  2011cites this paper
• Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer

  2011cites this paper
• Heterozygosity Loss at 22q and Lack of INI1 Gene Mutation in Gastrointestinal Stromal Tumor

  2011cites this paper
• Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.

  2011influential citation
• Correlation between p16 expression and malignant risk of gastrointestinal stromal tumor: evidence from nine studies.

  2011cites this paper
• Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival

  2011cites this paper
• Malignant Gliomas: Role of E2F1 Transcription Factor

  2011cites this paper
• Gastrointestinal Stromal Tumours: A Contemporary Review on Pathogenesis, Morphology and Prognosis

  2011influential citation
• Localization‐ and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32.31

  2010cites this paper
• Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosis

  2010cites this paper
• Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor.

  2010cites this paper
• Six months neoadjuvant imatinib improves resectability potential of gastric stromal tumors in Egyptian patients.

  2010cites this paper
• Multilayer-Analyse der Signaltransduktion und Zellzykluskontrolle in GIST

  2010cites this paper
• Predicting Malignant Potential of Gastrointestinal Stromal Tumors: Role of p16 and E2F1 Expression

  2010cites this paper
• Importance of CDK7 for G1 Re-Entry into the Mammalian Cell Cycle and Identification of New Downstream Networks Using a Computational Method

  2010cites this paper
• Unterschiedliche Aktivierung von Signalwegen zur Zellproliferation in mesenchymalen Tumoren des Gastrointestinaltrakts

  2010cites this paper
• Molekularbiologische Evaluation prognostischer Parameter in GIST

  2010cites this paper
• Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

  2009cites this paper
• Does imatinib turn recurrent and/or metastasized gastrointestinal stromal tumors into a chronic disease? – single center experience

  2009cites this paper
• Emerging roles of E2Fs in cancer: an exit from cell cycle control

  2009cites this paper
• Distinct biphasic histomorphological pattern in gastrointestinal stromal tumours (GISTs) with common primary mutations but divergent molecular cytogenetic progression

  2009cites this paper
• The Expressions of E 2 F 1 and p 53 in Gastrointestinal Stromal Tumors and Their Prognostic Significance

  2009influential citation
• The role of E2F activators in mouse development and tumorigenesis.

  2009cites this paper
• The Expressions of E2F1 and p53 in Gastrointestinal Stromal Tumors and Their Prognostic Significance

  2009cites this paper
• Expression und prognostische Bedeutung verschiedener Proteine bei gastrointestinalen Stromatumoren

  2009cites this paper
• Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

  2008cites this paper
• Genetic aberrations of gastrointestinal stromal tumors

  2008cites this paper
• Increased KIT signalling with up‐regulation of cyclin D correlates to accelerated proliferation and shorter disease‐free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions

  2008cites this paper
• Immune cells in primary gastrointestinal stromal tumors

  2008cites this paper
• P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases

  2008cites this paper
• p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome.

  2008cites this paper
• Loss of 9p leads to p16INK4A down‐regulation and enables RB/E2F1‐dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs)

  2008cites this paper
• Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway

  2008cites this paper
• Activation of Wnt/β‐catenin pathway mediates growth and survival in B‐cell progenitor acute lymphoblastic leukaemia

  2007cites this paper
• Characterization and functional studies of PPM1D in breast cancer

  2007cites this paper
• Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers

  2007cites this paper
• Progress in molecular diagnostics of gastrointestinal stromal tumors.

  2007cites this paper
• Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.

  2007cites this paper
• Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.

  2007cites this paper
• Surgical Management After Neoadjuvant Imatinib Therapy in Gastrointestinal Stromal Tumours (GISTs) with Respect to Imatinib Resistance Caused by Secondary KIT Mutations

  2007cites this paper
• Improved detection of KIT exon 11 duplications in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors.

  2007cites this paper
• Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors

  2007cites this paper
• Multicentric Sporadic Gastrointestinal Stromal Tumors (GISTs) of the Stomach With Distinct Clonal Origin: Differential Diagnosis to Familial and Syndromal GIST Variants and Peritoneal Metastasis

  2007cites this paper
• Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors

  2007influential citation
• E2F1 and Telomerase: Alliance in the Dark Side

  2006cites this paper
• Chromosomal imbalances and their target genes in gastrointestinal stromal tumors

  2006cites this paper
• Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.

  2006cites this paper
• KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).

  2006cites this paper
• Gastrointestinal stromal tumours overexpress fatty acid synthase

  2006cites this paper
• An update on molecular genetics of gastrointestinal stromal tumours

  2006cites this paper
• Oncotargets and Therapy Dovepress

  year unknowncites this paper